Subsequently, we analyzed the expression of EFNA1 and MMP13 in serum of GC patients in test cohort and validation cohort, and we found that EFNA1 and MMP13 levels did not differ significantly between different cohort (Supplementary Fig. S2). This evidence concerns the gene EFNA1 and gastric cancer.